AU Stock MarketDetailed Quotes

LTP LTR Pharma Ltd

Watchlist
  • 0.900
  • +0.050+5.88%
20min DelayMarket Closed Jul 5 16:00 AET
125.48MMarket Cap-90000P/E (Static)

LTR Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense
40.02%1.44M
3,488.95%1.03M
28.57K
Selling and administrative expenses
16.95%462.08K
--395.11K
----
-General and administrative expense
16.95%462.08K
--395.11K
----
Research and development costs
134.80%817.84K
--348.31K
----
Other operating expenses
-44.75%155.77K
886.86%281.95K
--28.57K
Operating profit
-40.02%-1.44M
-3,488.95%-1.03M
-28.57K
Net non-operating interest income (expenses)
-66.82%70
102.25%211
-9.37K
Non-operating interest income
-62.18%90
2,063.64%238
--11
Non-operating interest expense
-25.93%20
-99.71%27
--9.38K
Other net income (expenses)
-879.79%-19.29K
31.18%-1.97K
-2.86K
Other non-operating income (expenses)
-879.79%-19.29K
31.18%-1.97K
---2.86K
Income before tax
-41.65%-1.45M
-2,417.27%-1.03M
-40.8K
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
-41.65%-1.45M
-2,417.27%-1.03M
-40.8K
Net income continuous operations
-41.65%-1.45M
-2,417.27%-1.03M
---40.8K
Noncontrolling interests
Net income attributable to the company
-41.65%-1.45M
-2,417.27%-1.03M
-40.8K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-41.65%-1.45M
-2,417.27%-1.03M
-40.8K
Diluted earnings per share
-40.54%-0.0104
-2,366.67%-0.0074
-0.0003
Basic earnings per share
-40.54%-0.0104
-2,366.67%-0.0074
-0.0003
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense 40.02%1.44M3,488.95%1.03M28.57K
Selling and administrative expenses 16.95%462.08K--395.11K----
-General and administrative expense 16.95%462.08K--395.11K----
Research and development costs 134.80%817.84K--348.31K----
Other operating expenses -44.75%155.77K886.86%281.95K--28.57K
Operating profit -40.02%-1.44M-3,488.95%-1.03M-28.57K
Net non-operating interest income (expenses) -66.82%70102.25%211-9.37K
Non-operating interest income -62.18%902,063.64%238--11
Non-operating interest expense -25.93%20-99.71%27--9.38K
Other net income (expenses) -879.79%-19.29K31.18%-1.97K-2.86K
Other non-operating income (expenses) -879.79%-19.29K31.18%-1.97K---2.86K
Income before tax -41.65%-1.45M-2,417.27%-1.03M-40.8K
Income tax 000
Earnings from equity interest net of tax
Net income -41.65%-1.45M-2,417.27%-1.03M-40.8K
Net income continuous operations -41.65%-1.45M-2,417.27%-1.03M---40.8K
Noncontrolling interests
Net income attributable to the company -41.65%-1.45M-2,417.27%-1.03M-40.8K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -41.65%-1.45M-2,417.27%-1.03M-40.8K
Diluted earnings per share -40.54%-0.0104-2,366.67%-0.0074-0.0003
Basic earnings per share -40.54%-0.0104-2,366.67%-0.0074-0.0003
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg